Ratings by Oppenheimer (Andreas Argyrides)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/16/2026 | Opus Genetics | IRD | New Coverage | Outperform (N/A) |
5.03 (3.81) |
-24.25% | Details | |
| 3/12/2026 | Liquidia Technologies | LQDA | Maintain | Underperform (N/A) |
|
Details | ||
| 3/9/2026 | Abeona Therapeutics | ABEO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2026 | Gossamer Bio Inc. | GOSS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2026 | Moonlake Immunotherapeutics | MLTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2026 | Evommune Inc | EVMN | New Coverage | Outperform (N/A) |
18.85 (24.58) |
30.4% | Details | |
| 11/24/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2025 | Savara | SVRA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/12/2025 | Keros Therapeutics | KROS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2025 | Gossamer Bio Inc. | GOSS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2025 | Keros Therapeutics | KROS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Liquidia Technologies | LQDA | Maintain | Underperform (N/A) |
|
Details | ||
| 10/7/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2025 | Monopar Therapeutics | MNPR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2025 | Larimar Therapeutics | LRMR | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/16/2025 | Benitec BioPharma | BNTC | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2025 | Kala Bio | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2025 | Savara | SVRA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2025 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2025 | Monopar Therapeutics | MNPR | New Coverage | Outperform (N/A) |
33.93 (103.33) |
204.54% | Details | |
| 8/15/2025 | Savara | SVRA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2025 | Abeona Therapeutics | ABEO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2025 | Sarepta Therapeutics | SRPT | Upgrade | Outperform (Perform) |
11.93 (18.82) |
57.75% | Details | |
| 7/21/2025 | Sarepta Therapeutics | SRPT | Downgrade | Perform (Outperform) |
14.08 (11.93) |
-15.27% | Details | |
| 7/18/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/20/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/2/2025 | Abeona Therapeutics | ABEO | New Coverage | Outperform (N/A) |
6.24 (7.01) |
12.34% | Details | |
| 6/2/2025 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Outperform (N/A) |
34.50 (35.54) |
3.01% | Details | |
| 6/2/2025 | Kala Bio | KALA | New Coverage | Outperform (N/A) |
3.72 (1.09) |
-70.7% | Details | |
| 6/2/2025 | Savara | SVRA | New Coverage | Outperform (N/A) |
2.28 (5.74) |
151.75% | Details | |
| 5/29/2025 | Inflarx NV | IFRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/19/2025 | Liquidia Technologies | LQDA | Downgrade | Underperform (Perform) |
18.88 (71.21) |
277.17% | Details | |
| 5/15/2025 | Rani Therapeutics Holdsing s | RANI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2025 | ProQR Therapeutics N.V. | PRQR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2025 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2025 | Inflarx NV | IFRX | New Coverage | Outperform (N/A) |
1.49 (2.06) |
38.26% | Details | |
| 2/10/2025 | ARS Pharmaceuticals Inc | SPRY | New Coverage | Outperform (N/A) |
11.92 (7.74) |
-35.07% | Details | |
| 1/16/2025 | Keros Therapeutics | KROS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2025 | Korro Bio Inc. | KRRO | New Coverage | Outperform (N/A) |
37.62 (13.50) |
-64.11% | Details | |
| 1/10/2025 | ProQR Therapeutics N.V. | PRQR | New Coverage | Outperform (N/A) |
2.62 (1.70) |
-35.11% | Details | |
| 12/16/2024 | Keros Therapeutics | KROS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2024 | Benitec BioPharma | BNTC | New Coverage | Outperform (N/A) |
10.16 (12.99) |
27.85% | Details | |
| 10/16/2024 | Larimar Therapeutics | LRMR | New Coverage | Outperform (N/A) |
7.25 (3.73) |
-48.55% | Details | |
| 8/2/2024 | Rani Therapeutics Holdsing s | RANI | New Coverage | Outperform (N/A) |
2.83 (0.63) |
-77.74% | Details | |
| 6/25/2024 | Keros Therapeutics | KROS | New Coverage | Outperform (N/A) |
46.44 (11.10) |
-76.1% | Details | |
| 6/25/2024 | Clearside Biomedical | CLSD | New Coverage | Outperform (N/A) |
1.08 (0.41) |
-62.04% | Details | |
| 6/25/2024 | Liquidia Technologies | LQDA | New Coverage | Perform (N/A) |
12.20 (18.88) |
54.75% | Details | |
| 6/25/2024 | Gossamer Bio Inc. | GOSS | New Coverage | Outperform (N/A) |
0.65 (0.14) |
-78.46% | Details | |
| 6/25/2024 | Moonlake Immunotherapeutics | MLTX | New Coverage | Outperform (N/A) |
38.43 (20.41) |
-46.89% | Details |
